Pharma innovation incentives, medicines shortages, challenge Belgium's option paper progress

EURACTIV - Revision of the EU's pharmaceutical legislation remains the health priority for the Belgian presidency of the Council of the EU, but Belgium's efforts to complete the text remain challenged by the complexity of innovation incentives and medicines shortages. Read more

European,Flag,With,Belgium,Flag,In,Front,Of,Blue,Sky